Penumbra - Stock Price History | PEN

Historical daily share price chart and data for Penumbra since 2022 adjusted for splits. The latest closing stock price for Penumbra as of August 10, 2022 is 173.06.
  • The all-time high Penumbra stock closing price was 310.70 on April 28, 2021.
  • The Penumbra 52-week high stock price is 293.19, which is 69.4% above the current share price.
  • The Penumbra 52-week low stock price is 114.86, which is 33.6% below the current share price.
  • The average Penumbra stock price for the last 52 weeks is 214.47.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Penumbra Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2021 266.1209 175.6000 310.7000 175.6000 287.3200 64.18%
2020 193.1285 163.7900 272.8300 124.3400 175.0000 6.53%
2019 150.3881 123.0700 183.4000 115.8400 164.2700 34.43%
2018 130.1708 90.3500 165.9500 84.6000 122.2000 29.86%
2017 86.5337 64.0500 115.8500 64.0500 94.1000 47.49%
2016 59.2329 55.7100 79.3900 42.0000 63.8000 18.57%
2015 44.6995 41.3000 55.6000 36.5000 53.8100 0.00%
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $6.042B $0.748B
Penumbra, Inc. is an interventional therapies company. It designs, develops, manufactures and markets medical devices. The company's portfolio of products primarily addresses neuro and peripheral vascular medical conditions and clinical needs. Neuro products include Neurovascular Access, Neuron Access System, BENCHMARK Intracranial Access System, Penumbra System, 3D, Penumbra Coil 400, Penumbra SMART Coil and LIBERTY stent. Peripheral vascular products include Ruby Coil System, Penumbra Occlusion Device and Indigo System. It operates primarily in U.S., Europe, Canada and Australia. Penumbra, Inc. is headquartered in Alameda, California.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $227.578B 23.18
Edwards Lifesciences (EW) United States $62.887B 44.49
Alcon (ALC) Switzerland $36.987B 31.32
STERIS (STE) Ireland $20.913B 25.96
Teleflex (TFX) United States $11.693B 18.63
Fresenius Medical Care AG KGaA (FMS) Germany $10.936B 10.09
Globus Medical (GMED) United States $6.491B 32.38
Glaukos (GKOS) United States $2.370B 0.00
Integer Holdings (ITGR) United States $2.345B 18.34
Nevro (NVRO) United States $1.688B 0.00
Paragon 28 (FNA) United States $1.486B 0.00
AVANOS MEDICAL, INC (AVNS) United States $1.365B 20.90
Artivion (AORT) United States $0.860B 82.00